SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Corcoran David J

(Last)

(First)

(Middle)

C/O CURAXIS PHARMACEUTICAL CORPORATION

4819 EMPEROR BLVD., SUITE 400

(Street)

DURHAM

27707

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/29/2010

3. Issuer Name and Ticker or Trading Symbol
CURAXIS PHARMACEUTICAL Corp [ ASCH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,541,429	D
Common Stock	741,382	I	Trustee⁽¹⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Purchase Warrant	11/15/2006	12/31/2011	Common Sotck	15,000	$0.1	D
Stock Purchase Warrant	09/20/2006	12/31/2011	Common Stock	36,150	$0.1	I	Trustee⁽¹⁾
Employee Stock Option	06/20/2003⁽²⁾	06/20/2012	Common Stock	180,000	$0.83	D
Employee Stock Option	09/15/2004⁽³⁾	09/15/2013	Common Stock	60,000	$2	D
Employee Stock Option	01/17/2006⁽⁴⁾	01/17/2015	Common Stock	30,000	$8	D
Employee Stock Option	01/01/2008⁽⁵⁾	02/05/2017	Common Stock	90,000	$1.51	D

Explanation of Responses:

1. As Trustee for the Patrick S. Smith Irrevocable Trust u/d/a dated June 25, 1991.

2. These Stock options vest as to 20% on June 20, 2003 and 20% on each June 20th thereafter based on continued employment through June 20, 2007.

3. These Stock options vest as to 20% on September 15, 2004 and 20% on each September 15th thereafter based on continued employment through September 15, 2008.

4. These Stock options vest as to 20% on January 17, 2006 and 20% on each January 17th thereafter based on continued employment through January 17, 2010.

5. These Stock options vest as to 20% on January 1, 2008 and 20% on each January 1st thereafter based on continued employment through January 1, 2012.

	/s/ Judith S. T. Geaslen	08/06/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.